The cost of meloxicam 15 mg can vary based on several factors, including the pharmacy, insurance coverage, and whether a generic or brand-name version is purchased.
What influences meloxicam 15 mg pricing?
The price of meloxicam 15 mg is influenced by the formulation (brand-name vs. generic), the quantity purchased (e.g., 30-day or 90-day supply), and the specific retail pharmacy. Generic versions are typically less expensive than their brand-name counterparts. Insurance plans also play a significant role, with co-pays often differing for generic and brand-name drugs. Without insurance, out-of-pocket costs can be considerably higher [1].
Where can I find the lowest price for meloxicam 15 mg?
Comparing prices across different pharmacies, including major retail chains, independent pharmacies, and online pharmacies, can lead to savings. Prescription discount cards or coupons may also be used to reduce the out-of-pocket expense. Websites that aggregate prescription prices can be helpful in finding the most affordable option [1].
What is the typical price range for generic meloxicam 15 mg?
For a 30-day supply of generic meloxicam 15 mg, prices can range from approximately $10 to $30 without insurance, although this can fluctuate. A 90-day supply might offer a lower per-unit cost. These figures are estimates and actual costs can vary [1].
What are the patent and exclusivity details for meloxicam?
Meloxicam is a well-established nonsteroidal anti-inflammatory drug (NSAID) first approved by the FDA in 1997 [2]. As such, its primary patents have long expired, allowing for the widespread availability of generic versions. Information on specific patents and their expiration dates for meloxicam can be found on DrugPatentWatch.com [3].
Who manufactures generic meloxicam 15 mg?
Numerous pharmaceutical companies manufacture generic meloxicam 15 mg. These include major generic drug producers such as Teva Pharmaceuticals, Sandoz, and Mylan (now Viatris), among others. The availability of multiple manufacturers contributes to competitive pricing [2].
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?fuseaction=reports.general
3. https://www.drugpatentwatch.com/drug/meloxicam/